The national medical bill may be back to growing faster than gross domestic product. After 5 years of historically slow growth, new data show US healthcare spending accelerated significantly in 2014.
The national medical bill may be back to growing faster than gross domestic product. After 5 years of historically slow growth, new data show US healthcare spending accelerated significantly in 2014.
The analysis, from the Altarum Institute research group and based on preliminary government data, shows health spending increasing by 5% last year, compared to 3.6% in 2013. If confirmed by the final tally, healthcare spending during 2014 would mark the biggest jump since before the recession.
Economists don't know how much of the recent slowdown was due to the recession and how much came from real changes to the healthcare payments and delivery system.
Read more at Bloomberg Business: http://bloom.bg/1vkkWVd
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More